Provider Alert! HHSC to Add New Qulipta® Indication to Clinical Prior Authorization
Date: June 20, 2023 Attention: All Providers Effective Date: June 27, 2023 Call to action: Texas Children’s Health Plan (TCHP) would like to let providers know that effective June 27, 2023, Texas Health and Human Services (HHSC) will follow the Food and Drug Administration’s recent approval of new indication for atogepant (Qulipta®), to prevent chronic migraine in adults. How this impacts providers: Starting June 27, 2023, TCHP will implement the new indication for atogepant (Qulipta®) to prevent chronic migraine in adults. The new criteria...
